Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

Bibliographic Details
Main Authors:	Christopher H. Van Dyck, Ryan S. O'Dell, Adam P. Mecca
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Online Access:	https://doi.org/10.1002/trc2.12388

Similar Items

Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer's disease: Open peer commentary
by: Jeffrey Cummings
Published: (2023-07-01)

Clinical Trial Design in Alzheimer's Disease
by: Seyed Mehrdad Savar, et al.
Published: (2022-06-01)

Building clinically relevant outcomes across the Alzheimer's disease spectrum
by: Dorene M. Rentz, et al.
Published: (2021-01-01)

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations
by: Ronald C. Petersen, et al.
Published: (2023-10-01)

Clinical trials of new drugs for Alzheimer disease
by: Li-Kai Huang, et al.
Published: (2020-01-01)

Drug candidates in clinical trials for Alzheimer’s disease
by: Shih-Ya Hung, et al.
Published: (2017-07-01)

The search for clarity regarding “clinically meaningful outcomes” in Alzheimer disease clinical trials: CLARITY-AD and Beyond
by: Rawan Tarawneh, et al.
Published: (2024-02-01)

Association between clinical dementia rating and clinical outcomes in Alzheimer's disease
by: Krista L. Lanctôt, et al.
Published: (2024-01-01)

Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases
by: Henry Tseng, et al.
Published: (2023-09-01)

Clinical trials and the importance of biobanks in rare diseases
by: Nežić Lana, et al.
Published: (2018-01-01)

Effects of informant replacement in Alzheimer's disease clinical trials
by: Mikaela K. Nishida, et al.
Published: (2023-10-01)

Fluid biomarkers in clinical trials of Alzheimer’s disease therapeutics
by: Aaron eRitter, et al.
Published: (2015-08-01)

Guidance on minimally important clinical difference and trial size is needed.
by: Cook, J, et al.
Published: (2011)

A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer’s disease
by: Christopher H. van Dyck, et al.
Published: (2024-01-01)

Potential Applications of Artificial Intelligence in Clinical Trials for Alzheimer’s Disease
by: Younghoon Seo, et al.
Published: (2022-02-01)

Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials
by: Areeba Rashad, et al.
Published: (2022-12-01)

Attitudes toward clinical trials across the Alzheimer’s disease spectrum
by: Michelle M. Nuño, et al.
Published: (2017-10-01)

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
by: Nicholas C. Cullen, et al.
Published: (2020-09-01)

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
by: Martí Colom-Cadena, et al.
Published: (2020-03-01)

Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease
by: Kristl G. Claeys, et al.
Published: (2024-04-01)

Minimal clinically important difference: The basics
by: Julieta Aldana Salas Apaza, et al.
Published: (2021-04-01)

Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China
by: Yuxia Cao, et al.
Published: (2022-11-01)

Recognizing Atypical Presentations of Alzheimer’s Disease: The Importance of CSF Biomarkers in Clinical Practice
by: George P. Paraskevas, et al.
Published: (2022-12-01)

511 Analysis of Clinical Outcome Assessments in Clinical Trials for Huntington’s Disease
by: James Kim, et al.
Published: (2024-04-01)

Feasibility study for detection of retinal amyloid in clinical trials: The Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial
by: Jennifer Ngolab, et al.
Published: (2021-01-01)

Barriers and solutions to Alzheimer's disease clinical trial participation for Black Americans
by: Jordan Savold, et al.
Published: (2023-07-01)

Innovative Alzheimer's disease clinical trial design in the coming age of biomarkers
by: Hillerstrom, Hampus
Published: (2010)

Effectiveness of online education for recruitment to an Alzheimer's disease prevention clinical trial
by: Nabeel Saif, et al.
Published: (2020-01-01)

Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease
by: Camila Henriques de Aquino, et al.
Published: (2021-08-01)

Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities
by: Anna-Katharine Brem, et al.
Published: (2023-06-01)

Enriching the design of Alzheimer's disease clinical trials: Application of the polygenic hazard score and composite outcome measures
by: Sarah J. Banks, et al.
Published: (2020-01-01)

Clinical amyloid imaging in Alzheimer's disease.
by: Herholz, K, et al.
Published: (2011)

Alzheimer's and Parkinson's disease therapies in the clinic
by: Puja Chopade, et al.
Published: (2023-01-01)

Alzheimer’s disease: clinical management errors
by: V. A. Parfenov
Published: (2020-12-01)

Logopenic aphasia in Alzheimer's disease: clinical variant or clinical feature?
by: Ahmed, S, et al.
Published: (2012)

Logopenic aphasia in Alzheimer's disease: Clinical variant or clinical feature?
by: Ahmed, S, et al.
Published: (2012)

Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
by: Dana B. DiBenedetti, et al.
Published: (2023-02-01)

Minimal Clinically Important Difference of Scales Reported in Stroke Trials: A Review
by: Biswamohan Mishra, et al.
Published: (2024-01-01)

Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review.
by: Thompson, P, et al.
Published: (2012)

What is a minimal clinically important difference?
by: Harkness Michael
Published: (2023-12-01)